Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV B

PRESS RELEASE Stockholm, 23 March 2022 Today the Net Asset Values of the P Capital Partners IV B participation loan debentures are being announced. At the close of business on 22 March 2022, the Net Asset Value of the series A1 participation loan debentures amounted to EUR 98.69 each, and the Net Asset Value of the series B participation loan debenture amounted to EUR 987.54 each. The Net Asset Value of P Capital Partners IV B participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value

Arctic Bioscience New CFO Appointed

Arctic Bioscience has appointed Jone R. Slinning as the Company’s new CFO. Slinning will succeed Danielle Glenn, who has accepted a position with another company.Slinning has a broad and long experience from various industries, including auditing, the banking and finance sector, and different CFO positions. He comes from the position as CFO of Cflow Fish Handling and CFO for the consolidated Enflow Group, a company in the aquaculture industry. Slinning holds a Master of Economics degree (“siviløkonom”) from Norwegian School of Economics (NHH). “We are very pleased that Jone has accepted

Neles introduces the renewed Nelprof selection tool for automated process valves

Neles Corporation press release, March 23, 2022, at 10:00 a.m. EETThe complete Nelprof™ valve sizing and selection software for all intelligent automated process valves by Neles is now available as a free web-based tool. With its advanced control-valve selection features, the Nelprof™ tool allows fast and reliable selection of Neles™, Jamesbury™ and Easyflow by Neles™ branded intelligent automated process valves. First introduced in 1981, this latest version takes Nelprof™ to the next level with easy online access via your web browser. “Nelprof software utilizes intelligence based on

Stora Enso introduces renewable high-strength material for shopping and takeaway bags

STORA ENSO OYJ PRESS RELEASE 23 March 2022 at 10.00 EETTo support the shift to renewable and recyclable materials in shopping and takeaway bags, Stora Enso launches CarrEco Brown™. Made from 100% fresh fibers, the material has high strength and tear resistance properties and is also safe for direct food contact. By offering renewable, fiber-based materials suited for paper bags, Stora Enso accelerates the shift away from plastic. Stora Enso now expands its paper bag materials portfolio with CarrEco Brown, a new unbleached and uncoated board that is fully recyclable. Through its unique

Betsson appoints Roland Glasfors as new Vice President Communications and Investor Relations

Betsson AB has appointed Roland Glasfors as Vice President responsible for Communications, Sustainability and Investor Relations. He will be part of Betsson AB’s group management and report to CEO Pontus Lindwall. Roland Glasfors will begin his role on 2 May 2022.Roland Glasfors has a background within IR and strategy at gaming development company NetEnt and payment service provider Trustly, where he most recently served as Head of Investor Relations. He also has many years of experience from institutional equity sales, both in Sweden and internationally. ”Roland’s extensive experience

Vattenfall enables fossil-free parcel delivery for Instabox

Vattenfall and the delivery company Instabox have started an international collaboration to provide charging infrastructure for Instabox’s electric vehiclefleet. By the end of 2022, Vattenfall will operate approximately 400 charge points on Instabox’s terminals in Sweden, Denmark and the Netherlands.Instabox is an international last-mile delivery company that delivers packages for a large number of e-commerce companies. "We are pleased that Instabox has chosen Vattenfall and our complete solution Power-as-a-Service for charging infrastructure at its logistics terminals in three countries.

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV

PRESS RELEASE Stockholm, 23 March 2022 Today the Net Asset Values of the P Capital Partners IV participation loan debentures is at the close of business on 22 March 2022 EUR 99.15 per each of the series A1 participation loan debentures. The Net Asset Value of P Capital Partners IV participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set, as a result of P Capital Partners IV increasing its contributed capital by EUR 7 million, through the issuance of 73,264 series A1

Alligo publishes Annual and Sustainability Report 2021

Alligo publishes its Annual and Sustainability Report for the financial year 2021 on the company’s website today.The Annual Report in Swedish is available at the company’s website where it can be downloaded as PDF and in European Single Electronic Format (ESEF). An English translation of the report will be available at www.alligo.com/en/investor-relations/reports-presentations/ during the week of 4 April. For further information, please contact:Clein Ullenvik, CEO & Presidentor:Irene Wisenborn Bellander, CFOTel +46 8 712 00 00ir@alligo.com This information is such that

TORM plc Annual Report 2021

TORM plc (“TORM”) (ticker: TRMD A on Nasdaq in Copenhagen and TRMD on Nasdaq in New York) has released its Annual Report for 2021 (the “Annual Report”), which includes TORM’s 2021 audited financial statements and is available on www.torm.com.   For easy reference to TORM’s results for 2021, please also see company announcement no. 02 2022, in which TORM announced the results for the fourth quarter and twelve months ending 31 December 2021, released on 02 March 2022.   For 2022, TORM expects higher rates than in 2021 (2021: USD 13,703/day) and a net profit before tax (2021: loss

Nordic Nanovector ASA – Mandatory notification of trade – settlement of PSUs

Oslo, Norway, 23 March 2022 Reference is made to the stock exchange announcement made by Nordic Nanovector ASA's (OSE: NANOV) (the "Company") on 31 January 2019, regarding allocation of 259,000 PSUs to employees in accordance with the authorisation granted at the Company’s annual general meeting held 30 May 2018 (the “2018 AGM”). Each vested PSU will give the holder the right to receive one share in the Company at an exercise price corresponding to the par value of the shares being NOK 0.20. The total program ended at 42,675 vested PSUs which were exercised on 22 March 2022. Out of

NOTICE TO THE ANNUAL GENERAL MEETING OF HEXPOL AB (publ)

Shareholders of HEXPOL AB are hereby summoned to the Annual General Meeting (AGM) to be held at 3 p.m. CET on Thursday, 28 April 2022 at Clarion Malmö Live at the address Dag Hammarskjölds torg 2, Malmö, Sweden. Due to the continued spread of the coronavirus, precautionary measures will be implemented in connection with the AGM. The AGM will be held as short as possible and no food will be offered after the AGM. Shareholders, proxy holders and assistants showing any symptoms of infection should refrain from participating in the AGM. Shareholders are encouraged to carefully consider the

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Lund, Sweden, March 23, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the ongoing OPTIMIZE-1 clinical Phase Ib/II trial in first-line metastatic pancreatic cancer with the company’s lead asset, mitazalimab. Safety evaluation of the second dose-escalation cohort (900 µg/kg of mitazalimab in combination with mFOLFIRINOX) has concluded, which marks the successful completion of the Phase Ib part of the study. The Data Review Committee has declared the 900 µg/kg mitazalimab dose to be safe and recommended that the dosing level should be continued for the

BioStock: Immunicum’s strategy for fighting tumour recurrence

Tumour recurrence is the underlying cause of the majority of cancer deaths worldwide. It is thus considered one of the most pressing challenges within the oncology field. Swedish immuno-oncology company Immunicum is addressing this challenge with relapse vaccine candidate DCP-001, which is currently in phase II clinical stage. BioStock takes a closer look.Read the full article at biostock.se: https://www.biostock.se/en/2022/03/immunicums-strategy-for-fighting-tumour-recurrence/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Pihlajalinna starts repurchasing own shares for its M&A transactions and incentive programme

Pihlajalinna Plc                        Stock Exchange Release          23 March 2022 at 9.30 a.m.. Pihlajalinna starts repurchasing own shares for its M&A transactions and incentive programme The Board of Directors of Pihlajalinna Plc has decided to start repurchasing the company’s own shares on the basis of the authorisation given by the Annual General Meeting on 15 April 2021. The shares shall be repurchased to be used for M&A transactions and as part of the incentive programme. The maximum number of shares to be acquired is 120,000, corresponding to 0.53% of the total number

SciBase receives largest electrode order from a single clinic valued at 60k€

STOCKHOLM, SWEDEN, — March 23, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders,  announced today that it has received its single largest order to date from a single clinic. The order for nearly 2,000 electrodes was received from an existing customer, a private Dermatology clinic in Germany. The order was valued at around 60k€ and will be delivered in April. The company has seen a significant increase in order volume following the announcement of an 8% increase in electrode prices from April 1.“It is very

Realheart to establish Australian subsidiary

Press release 23 March, 2022 Realheart, who is developing the world's first artificial four-chamber heart, is setting up a subsidiary in Australia to take advantage of the knowledge and financial benefits offered by the Australian market related to product development and clinical trials.Scandinavian Real Heart Pty Ltd will be led and run by Dr Marianne Hellers, without any other employees. She holds a degree in Microbiology from Stockholm University and has extensive experience in the Australian life science community as well as a large network that can be valuable for Realheart in

Loomis announces new targets and presents strategy for 2022 – 2024

At the Capital Markets Day, which is held in a digital format today, Loomis announces new targets and presents an updated strategy under the heading “At the Centre of the Payment Ecosystem”.   The strategy means that Loomis will move further up the value chain by: 1) accelerating the core business, 2) increased focus on services with recurring revenue, 3) combining physical and digital customer offerings, 4) being the leading player in the market within ESG and 5) continuing to develop the Loomis model.   Loomis’ dividend policy, stating that 40 – 60 percent of annual net

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 75 - 23 MARCH 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

XNK Therapeutics Reports First Patient Treated in Phase II Study in Multiple Myeloma

XNK Therapeutics AB (“XNK”) today announced that the first patient has been treated in a Phase II clinical study using XNK’s leading autologous natural killer (NK) cell-based candidate drug in combination with Sanofi’s anti-CD38 antibody Sarclisa (Isatuximab).“Having the first patient treated with NK cells in this clinical study is an important milestone in the clinical development of our leading drug candidate,” said Johan Aschan, CMO of XNK Therapeutics. “The study is progressing well, and we look forward to the results.” The present investigator-initiated, open, randomized, controlled,

Pihlajalinna starts a share-based incentive program

Pihlajalinna Plc             Stock Exchange Release              23 March 2022 at 9:00 a.m. Pihlajalinna starts a share-based incentive program The Board of Directors of Pihlajalinna Plc has adopted a share-based incentive program for the key persons of the company. The objective of the incentive program is to align the interests of the key persons with the interests of the Pihlajalinna shareholders in order to increase the value of the company. The program is to commit the key persons to the company and offer for the key persons a competitive compensation for superior performance. In

AFRY awarded the EPCM project for the Horizonte Minerals ferronickel project in Brazil

Araguaia Niquel Metais Ltda., a wholly owned subsidiary of Horizonte Minerals Plc, has awarded AFRY the Engineering, Procurement and Construction Management (EPCM) contract for the development of its Araguaia ferronickel project in Brazil.Nickel is a fundamental material in our everyday lives. As a critical component in both stainless steel and new battery technology, nickel is also a key enabler of the clean energy transition. New technology innovations, ethical behaviour as well as reduced water usage and a low carbon footprint are important priorities for new nickel mining operations and

There are no items matching the current filter
There are no more items matching the current filter
Back to top